The poster " The IFN-γ Biosensor - A universal tool for IFN-γ detection in cellular co-culture assays” is available on Medigene's website: "Release of IFN-γ is one of the most common parameters used ...

Planegg/Martinsried, November 11, 2024.Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused ...

Members of Medigene management as expert speakers, Prof. Dolores Schendel, Chief Scientific Officer and Kirsty Crame, MD, Vice President, Clinical Strategy & Development Presentations and seminars ...

DelveInsight’s Non-Hodgkin Lymphoma pipeline report depicts a robust space with 200+ Non-Hodgkin Lymphoma companies working ...

T-Mobile is one of the fastest-growing carriers in the United States thanks to aggressive pricing, marketing, and a penchant for doing the unexpected. The Uncarrier has significantly shaken up the ...

Panelists discuss how to operationalize bispecific antibody (BsAb) therapy in community practices, summarizing the toxicities associated with CD3×CD20 BsAbs and presenting consensus recommendations ...

An 11-year-old boy with complex special needs was ready to leave a Toronto hospital, but his parents were refusing to take him home. Eight days earlier, the boy had been admitted while suffering a ...

Researchers at the Center for Genomic Regulation (CRG) in Barcelona have created the first blueprint of the human spliceosome, the most complex and intricate molecular machine inside every cell.

Incorrect comments about alcohol’s effect on mental health are just the latest for Mike King and his one-man crusade against the world. There’s something darkly hilarious about reading that ...

The task of moving engine covers “between supplier containers and a mobile sequencing dolly” isn’t especially exciting, but it demonstrates several of the new robot’s capabilities working ...

The data show that the combination of nasal anti-CD3 plus semaglutide improves liver ... potential for combination therapies in addressing complex metabolic and inflammatory conditions." ...